KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Other Operating Expenses (2016 - 2025)

Medpace Holdings' Other Operating Expenses history spans 11 years, with the latest figure at $503.3 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 40.35% year-over-year to $503.3 million; the TTM value through Dec 2025 reached $1.8 billion, up 21.75%, while the annual FY2025 figure was $1.8 billion, 21.75% up from the prior year.
  • Other Operating Expenses reached $503.3 million in Q4 2025 per MEDP's latest filing, up from $463.2 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $503.3 million in Q4 2025 to a low of $182.8 million in Q1 2021.
  • Average Other Operating Expenses over 5 years is $321.9 million, with a median of $346.7 million recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: fell 0.98% in 2024, then surged 40.35% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $221.9 million in 2021, then grew by 25.85% to $279.2 million in 2022, then increased by 29.72% to $362.2 million in 2023, then fell by 0.98% to $358.6 million in 2024, then soared by 40.35% to $503.3 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Other Operating Expenses are $503.3 million (Q4 2025), $463.2 million (Q3 2025), and $423.5 million (Q2 2025).